Table 1.
Subject baseline characteristics.
| Initial diagnosis cohort |
Post eradication therapy cohort |
|||
|---|---|---|---|---|
| Per protocol set | Per protocol set | |||
| Age (years) | ||||
| N | 189 | 68 | ||
| Mean (SD) | 48.4 (14.85) | 49.7 (15.33) | ||
| Median [range] | 48.3 [20.2; 82.8] | 50.0 [18.5; 82.3] | ||
| Gender | ||||
| Male | % (n/N) | 41.3% (78/189) | 36.8% (25/68) | |
| Female | % (n/N) | 58.7% (111/189) | 63.2% (43/68) | |
| Ethnic origin | ||||
| Caucasian | % (n/N) | 52.9% (100/189) | 23.5% (16/68) | |
| African-American | % (n/N) | 5.3% (10/189) | 5.9% (4/68) | |
| Asian-Pacific | % (n/N) | 2.1% (4/189) | 5.9% (4/68) | |
| Hispanic | % (n/N) | 38.6% (73/189) | 64.7% (44/68) | |
| Other | % (n/N) | 1.1% (2/189) | – | |
| BMI (kg/m2) | ||||
| Mean (SD) | 28.9 (6.12) | 30.6 (7.44) | ||
| Median [range] | 28.1 [16.3; 50.3] | 29.0 [19.7; 61.3] |
BMI: body mass index; SD: standard deviation.